[Solutions for Fluid Treatment and Outcome - an Update]

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Critical Care

Background:

• Fluid therapy is a common medical intervention to restore fluid balance.
• Glycocalyx integrity is vital for fluid exchange and transport between vascular and tissue compartments.
• The revised Starling principle enhances understanding of fluid dynamics.

Purpose of the Study:

• To review current fluid therapy strategies and their clinical implications.
• To evaluate the efficacy and safety of different fluid solutions, including crystalloids and colloids.
• To discuss the role of albumin in specific patient populations.

Main Methods:

• Literature review of fluid therapy principles and clinical evidence.
• Analysis of crystalloid solutions, focusing on balanced solutions.
• Evaluation of colloid solutions, including natural (albumin) and synthetic types.
• Discussion of the revised Starling principle in clinical practice.

Main Results:

• Balanced crystalloid solutions appear to have fewer side effects.
• Colloid solutions offer a greater volume effect when the vascular barrier is intact but carry risks.
• Synthetic colloids are restricted in critically ill patients in Europe.
• Albumin 20% in hypalbuminemic patients with cardiovascular disease reduces acute kidney injury and offers other benefits.

Conclusions:

• Fluid therapy should aim for euvolemia with minimal side effects.
• The choice of fluid depends on vascular barrier integrity and patient-specific factors.
• Albumin therapy shows clinical benefits in selected hypalbuminemic patients.
• Future individualized colloid therapies may impact patient outcomes, but require further investigation.